Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.
Frequently asked questions
What sector does Crystalvue Medical Corporation (6527) operate in?
Crystalvue Medical Corporation belongs to the Other sector and operates in the Medical Instruments & Supplies industry.
What is Crystalvue Medical Corporation (6527) current stock price?
As of the latest data, Crystalvue Medical Corporation stock price is NT$75.00, with a previous close of NT$73.20. Crystalvue Medical Corporation gained NT$1.80 in the last trading session, representing a 2.46% increase.
What is Crystalvue Medical Corporation (6527) current market capitalization?
Crystalvue Medical Corporation market cap is approximately 1.90 billion.
What is Crystalvue Medical Corporation (6527) Earnings Per Share (EPS)?
The trailing EPS is NT$5.58.
What is Crystalvue Medical Corporation (6527) Price-to-Earnings (P/E) ratio?
Crystalvue Medical Corporation current P/E ratio is 13.44.
Does Crystalvue Medical Corporation (6527) pay dividends?
Yes. Crystalvue Medical Corporation pays annual dividends with an annualized yield of 3.87% and an estimated annual payout of NT$2.90 per share.
When is the next ex-dividend date for Crystalvue Medical Corporation (6527)?
The next ex-dividend date is scheduled for July 21, 2027.
What is Crystalvue Medical Corporation (6527) beta (volatility) score?
Crystalvue Medical Corporation has a beta of 0.702, indicating lower volatility than the overall market.
